Skip to main content
Top
Published in: Digestive Diseases and Sciences 5/2020

01-05-2020 | Visceral Ischemia | Correspondence

Non-occlusive Mesenteric Ischemia as a Fatal Complication in Acute Pancreatitis: A Brief Radiological Comment

Authors: Maria Antonietta Mazzei, Susanna Guerrini, Francesco Gentili, Ilaria Monteleone, Gabriele Lucii, Francesco Giuseppe Mazzei, Luca Volterrani

Published in: Digestive Diseases and Sciences | Issue 5/2020

Login to get access

Abstract

Non-occlusive mesenteric ischemia (NOMI) is the result of the reduction of mesenteric blood supply, due to mesenteric arterial vasoconstriction secondary to hypotension in cases of shock, septicemia, dehydration, heart surgery, or major abdominal surgery. NOMI represents a complex and often misdiagnosed syndrome. Imaging, and in particular CT, has a remarkable importance in NOMI, and despite its complexity, it could allow an early diagnosis and an improved management resulting in life-threatening therapeutic approaches, much better than in the past, provided it is correctly performed and interpreted by experienced radiologists.
Literature
2.
go back to reference Mazzei MA, Guerrini S, Cioffi Squitieri N, et al. Non-obstructive mesenteric ischemia after cardiovascular surgery: not so uncommon. Ann Thorac Cardiovasc Surg. 2014;20:253–255.CrossRef Mazzei MA, Guerrini S, Cioffi Squitieri N, et al. Non-obstructive mesenteric ischemia after cardiovascular surgery: not so uncommon. Ann Thorac Cardiovasc Surg. 2014;20:253–255.CrossRef
Metadata
Title
Non-occlusive Mesenteric Ischemia as a Fatal Complication in Acute Pancreatitis: A Brief Radiological Comment
Authors
Maria Antonietta Mazzei
Susanna Guerrini
Francesco Gentili
Ilaria Monteleone
Gabriele Lucii
Francesco Giuseppe Mazzei
Luca Volterrani
Publication date
01-05-2020

Other articles of this Issue 5/2020

Digestive Diseases and Sciences 5/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.